{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "'''\n",
    "this code is for retrieve all the desired PubMed Format elements: PMID, PT, OT, MH from a list of PMIDs by \n",
    "using the webpage https://pubmed.ncbi.nlm.nih.gov/32790733/?format=pubmed \n",
    "The input list is a result from SCAIView output back end file\n",
    " '''\n",
    "\n",
    "import pandas as pd\n",
    "import requests\n",
    "from bs4 import BeautifulSoup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "#1. obtain a unique list of PMIDs, because one PMID may link to multiple Clinical Trial IDs.\n",
    "def PMID_input(file):\n",
    "    \"\"\"\n",
    "    Get the input NCTID as a list\n",
    "    :param file\n",
    "    :return the list\n",
    "    \"\"\"\n",
    "    PMID_list = []\n",
    "    filepath = \"input\\\\\"+file\n",
    "    df = pd.read_csv(filepath, sep = '\\t', header = 0)\n",
    "    print(\"The \"+file+\" contains \"+str(df.shape[0])+\" rows in total.\")\n",
    "    PMID_list = df['PMID'].dropna().tolist()\n",
    "    print(\"There are \"+str(len(PMID_list))+\" rows with PMID.\")\n",
    "    PMID_list_uni= list(set(PMID_list))\n",
    "    print(\"There are \"+str(len(PMID_list_uni))+\" unique PMIDs.\")\n",
    "    return PMID_list_uni"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Please give the file name contains PMID list:results-ivermectin.txt\n",
      "The results-ivermectin.txt contains 2058 rows in total.\n",
      "There are 1972 rows with PMID.\n",
      "There are 138 unique PMIDs.\n"
     ]
    }
   ],
   "source": [
    "SCAIviewfile = input('Please give the file name contains PMID list:' )\n",
    "PMID_list_uni = PMID_input(SCAIviewfile)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "processing https://pubmed.ncbi.nlm.nih.gov/32497632/?format=pubmed...\n",
      "{'PMID': '32497632', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'Aminoquinolines/therapeutic use;AntiBacterial Agents/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus/*isolation & purification;COVID19;COVID19 Vaccines;Coronavirus Infections/*drug therapy/prevention & control/virology;Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy/virology;SARSCoV2;Viral Vaccines/administration & dosage;DA 2020/08/25 06:00', 'SI': '', 'TI': 'Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical ', 'GR': ''}\n",
      "1 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32560227/?format=pubmed...\n",
      "{'PMID': '32560227', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;coronavirus;therapies;vaccines', 'MH': 'DA 2020/06/21 06:01', 'SI': '', 'TI': 'Vaccines and Therapies in Development for SARS-CoV-2 Infections.', 'GR': 'R01AI13976802/National Institute of Allergy and Infectious Diseases/'}\n",
      "2 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32916249/?format=pubmed...\n",
      "{'PMID': '32916249', 'PT': 'Editorial', 'OT': 'O  NNLM;SARSCoV2;control;diagnostics;hygiene;therapeutics;vaccination', 'MH': 'COVID19/diagnosis/drug therapy/*prevention & control;COVID19 Serological Testing;COVID19 Vaccines/immunology;Delivery of Health Care;Hand Disinfection;*Health Resources;Humans;RealTime Polymerase Chain Reaction;*SARSCoV2;DA 2021/01/01 06:00', 'SI': '', 'TI': 'Integrated control of COVID-19 in resource-poor countries.', 'GR': ''}\n",
      "3 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32784499/?format=pubmed...\n",
      "{'PMID': '32784499', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;antiviral;coronavirus;remdesivir;vaccine', 'MH': 'DA 2020/08/14 06:01', 'SI': '', 'TI': 'Emerging Therapeutic Modalities against COVID-19.', 'GR': '1R01CA24119401A1/NH/NIH HHS/United States;1R01HL14702801A1/NH/NIH HHS/United States'}\n",
      "4 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32871201/?format=pubmed...\n",
      "{'PMID': '32871201', 'PT': 'Journal Article;Research Support, N.I.H., Extramural;Review', 'OT': 'O  NNLM;*Bioinspired materials;*Drug delivery;*Hierarchical selfassembly;*Polypeptides;*Recombinant proteins', 'MH': 'DA 2020/09/02 06:00', 'SI': '', 'TI': 'Recent trends in protein and peptide-based biomaterials for advanced drug delivery.', 'GR': 'R35 GM127042/GM/NIGMS NIH HHS/United States;R21 CA237705/CA/NCI NIH HHS/United States'}\n",
      "5 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32562159/?format=pubmed...\n",
      "{'PMID': '32562159', 'PT': 'Comparative Study;Journal Article;Observational Study', 'OT': 'O  NNLM;Combination therapy;Coronavirus disease 2019;Length of stay in hospitals (ALOS)', 'MH': 'Adult;Aged;Azithromycin/administration & dosage;COVID19/complications/*drug therapy;Drug Combinations;Drug Therapy, Combination;Female;Hospitalization/*statistics & numerical data;Humans;Hydroxychloroquine/administration & dosage;Iran;Length of Stay;Levofloxacin/administration & dosage;Lopinavir/administration & dosage;Male;Meropenem/administration & dosage;Middle Aged;Naproxen/administration & dosage;Oseltamivir/administration & dosage;Pneumonia, Viral/*drug therapy/virology;Prednisolone/administration & dosage;Retrospective Studies;Ritonavir/administration & dosage;Treatment Outcome;Vancomycin/administration & dosage;DA 2020/12/15 06:00', 'SI': '', 'TI': 'The clinical value of two combination regimens in the Management of Patients ', 'GR': ''}\n",
      "6 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32814759/?format=pubmed...\n",
      "{'PMID': '32814759', 'PT': \"Journal Article;Research Support, NonU.S. Gov't\", 'OT': '', 'MH': 'Animals;Antiviral Agents/pharmacology;Betacoronavirus/*physiology;COVID19;Cell Death/drug effects;Chlorocebus aethiops;Coronavirus Infections/*metabolism/virology;Drug Evaluation, Preclinical/*methods;Hydroxychloroquine/pharmacology;Imatinib Mesylate/pharmacology;Lysosomes/drug effects;Pandemics;Pneumonia, Viral/*metabolism/virology;Protein Kinase Inhibitors/pharmacology;RNA, Viral/drug effects;SARSCoV2;Vero Cells;Viral Load/drug effects;Virus Replication/*drug effects;DA 2020/09/02 06:00', 'SI': '', 'TI': 'On-target versus off-target effects of drugs inhibiting the replication of ', 'GR': ''}\n",
      "7 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33055059/?format=pubmed...\n",
      "{'PMID': '33055059', 'PT': 'Journal Article', 'OT': 'O  NNLM;2019nCoV;COVID19;SARS;SARSCoV2;coronavirus;dexamethasone;hydroxychloroquine;ivermectin;remdesivir;statin;statins', 'MH': 'DA 2020/10/16 06:01', 'SI': '', 'TI': 'Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities ', 'GR': ''}\n",
      "8 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33324210/?format=pubmed...\n",
      "{'PMID': '33324210', 'PT': 'Journal Article', 'OT': 'O  NNLM;COVID19;coronavirus;cytokine storm;fibrosis;macrophage', 'MH': 'DA 2020/12/17 06:01', 'SI': '', 'TI': 'Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019.', 'GR': ''}\n",
      "9 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32717568/?format=pubmed...\n",
      "{'PMID': '32717568', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*Chloroquine;*Coronavirus;*Lopinavir;*Remdesivir;*Ribavirin;*Ritonavir;*SARSCoV2', 'MH': 'Animals;AntiBacterial Agents/administration & dosage/metabolism;Antibodies, Monoclonal, Humanized/administration & dosage/metabolism;Antimalarials/administration & dosage/metabolism;Antiviral Agents/*administration & dosage/metabolism;COVID19/*drug therapy/metabolism;Clinical Trials as Topic/methods;Cytochrome P450 CYP3A Inhibitors/administration & dosage/metabolism;Drug Approval/*methods;Drug Therapy, Combination;Humans;Hydroxychloroquine/administration & dosage/metabolism;SARSCoV2/*drug effects/metabolism;United States/epidemiology;DA 2020/12/29 06:00', 'SI': '', 'TI': 'FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) ', 'GR': ''}\n",
      "10 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33178016/?format=pubmed...\n",
      "{'PMID': '33178016', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Middle East respiratory syndrome coronavirus;coronavirus;coronavirus disease 2019;severe acute respiratory syndrome coronavirus2;therapeutic interventions;transmission', 'MH': 'DA 2020/11/13 06:01', 'SI': '', 'TI': 'COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future ', 'GR': ''}\n",
      "11 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32977703/?format=pubmed...\n",
      "{'PMID': '32977703', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Aedes;Flavivirus;Zika;dengue;epidemiology', 'MH': 'DA 2020/09/27 06:01', 'SI': '', 'TI': 'Dengue and Zika Viruses: Epidemiological History, Potential Therapies, and Promising ', 'GR': 'N.M.S. acknowledges FCTMCTES fellowship SFRH/BD/144585/2019/Fundação para a Ciência ;I.C.M. acknowledges FCTMCTES program \"Concurso de Estímulo ao Emprego Científico\" ;I.C.M. acknowledges support from Science Frontiers Research Prize of 2010/Fundação '}\n",
      "12 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33024717/?format=pubmed...\n",
      "{'PMID': '33024717', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiviral drugs;COVID19;Coronavirus;Eculizumab;Enoxaparin;Hydroxychloroquine;Opinion review;Pandemic;SARSCoV2;Tocilizumab;Treatment', 'MH': 'DA 2020/10/08 06:01', 'SI': '', 'TI': 'Current status of COVID-19 treatment: An opinion review.', 'GR': ''}\n",
      "13 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32344679/?format=pubmed...\n",
      "{'PMID': '32344679', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;One Health;SARSCoV2;control;diagnosis;epidemiology;genetics;outbreak;pneumonia;public health;treatment', 'MH': 'DA 2020/04/30 06:01', 'SI': '', 'TI': 'The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, ', 'GR': ''}\n",
      "14 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32711111/?format=pubmed...\n",
      "{'PMID': '32711111', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*ACE2;*Ang (17);*Covid19;*Immunomodulators;*Remdesivir;*SARSCoV2', 'MH': 'AngiotensinConverting Enzyme 2;Antiviral Agents/*therapeutic use;Betacoronavirus/chemistry/*metabolism;COVID19;Coronavirus Infections/*drug therapy/prevention & control/virology;Drug Repositioning/*methods;Humans;Life Cycle Stages/*drug effects;Molecular Targeted Therapy/*methods;Pandemics/prevention & control;PeptidylDipeptidase A/metabolism;Pneumonia, Viral/*drug therapy/prevention & control/virology;ReninAngiotensin System/drug effects;SARSCoV2;Spike Glycoprotein, Coronavirus/immunology/metabolism;Viral Vaccines/immunology;Virus Internalization/drug effects;Virus Replication/drug effects;DA 2020/09/10 06:00', 'SI': '', 'TI': 'Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising ', 'GR': ''}\n",
      "15 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33132570/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '33132570', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Coronavirus;Coronavirus disease2019;Heparin;Hydroxychloroquine;Remdesvir;SARSCoV2;Tocilizumab', 'MH': 'DA 2020/11/03 06:01', 'SI': '', 'TI': 'Current Approaches to COVID-19: Therapy and Prevention.', 'GR': ''}\n",
      "16 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33398233/?format=pubmed...\n",
      "{'PMID': '33398233', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'DA 2021/01/06 06:01', 'SI': '', 'TI': 'Novel coronavirus disease (COVID-19) pandemic: A recent mini review.', 'GR': ''}\n",
      "17 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33482149/?format=pubmed...\n",
      "{'PMID': '33482149', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*COVID19;*Drug safety and drug efficacy;*Mutation;*RNA therapeutics;*SARSCoV2', 'MH': 'DA 2021/01/23 06:00', 'SI': '', 'TI': 'Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts ', 'GR': ''}\n",
      "18 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32768971/?format=pubmed...\n",
      "{'PMID': '32768971', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Anakinra;Convalescent plasma;Corticosteroids;Hydroxychloroquine;SARSCoV2;Vaccine', 'MH': 'Animals;Antiviral Agents/*pharmacology;Betacoronavirus/drug effects/isolation & purification;COVID19;Coronavirus Infections/*drug therapy/epidemiology/virology;Drug Design;Humans;Pandemics;Pneumonia, Viral/*drug therapy/epidemiology/virology;Public Health;SARSCoV2;Viral Vaccines/administration & dosage;DA 2020/09/08 06:00', 'SI': '', 'TI': 'Natural history of COVID-19 and current knowledge on treatment therapeutic options.', 'GR': ''}\n",
      "19 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32903349/?format=pubmed...\n",
      "{'PMID': '32903349', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;antivirals;coronaviruses;treatment', 'MH': 'DA 2020/09/10 06:01', 'SI': '', 'TI': 'Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?', 'GR': ''}\n",
      "20 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32756480/?format=pubmed...\n",
      "{'PMID': '32756480', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;MERSCoV;SARSCoV;SARSCoV2;adjunctive therapy;antiparasite;antiviral;clinical trial;immunotherapy;molecular immune response', 'MH': '*Adaptive Immunity;AntiInflammatory Agents/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus/isolation & purification/*physiology;COVID19;Coronavirus Infections/immunology/*pathology/therapy/virology;Humans;Immunotherapy;Middle East Respiratory Syndrome Coronavirus/isolation & purification/physiology;Open Reading Frames/genetics;Pandemics;Pneumonia, Viral/immunology/*pathology/therapy/virology;SARSCoV2;DA 2020/08/13 06:00', 'SI': '', 'TI': 'COVID-19: The Immune Responses and Clinical Therapy Candidates.', 'GR': ''}\n",
      "21 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32868970/?format=pubmed...\n",
      "{'PMID': '32868970', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiinflammatory agents;Antiviral drugs;COVID19;Corona virus;SARSCoV2', 'MH': 'DA 2020/09/02 06:01', 'SI': '', 'TI': 'Novel β-Coronavirus (SARS-CoV-2): Current and future aspects of pharmacological ', 'GR': ''}\n",
      "22 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33227287/?format=pubmed...\n",
      "{'PMID': '33227287', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Repurposed drugs;SARSCoV2;Therapeutic targets;Vaccines', 'MH': 'Adrenal Cortex Hormones/*therapeutic use;Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/epidemiology/*therapy;Drug Repositioning;Epidemics;Humans;Immunization, Passive;*Medicine, Ayurvedic;*Medicine, Chinese Traditional;*SARSCoV2/immunology;Viral Vaccines;DA 2020/12/30 06:00', 'SI': '', 'TI': 'A comprehensive review on potential therapeutics interventions for COVID-19.', 'GR': ''}\n",
      "23 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33317461/?format=pubmed...\n",
      "{'PMID': '33317461', 'PT': 'Journal Article;Randomized Controlled Trial', 'OT': 'O  NNLM;Arbidol;COVID19;Corona virus;Efficacy', 'MH': 'Adult;Aged;Antiviral Agents/*therapeutic use;COVID19/*drug therapy;Drug Combinations;Female;Humans;Hydroxychloroquine/therapeutic use;Indoles/*therapeutic use;Lopinavir/therapeutic use;Male;Middle Aged;Pandemics;Ritonavir/therapeutic use;SARSCoV2;DA 2020/12/19 06:00', 'SI': '', 'TI': 'Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial.', 'GR': '17640/Iran University of Medical Sciences/'}\n",
      "24 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33191206/?format=pubmed...\n",
      "{'PMID': '33191206', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'Adenosine Monophosphate/analogs & derivatives/chemistry/pharmacology/therapeutic use;Alanine/analogs & derivatives/chemistry/pharmacology/therapeutic use;AntiInflammatory Agents/chemistry/pharmacology/*therapeutic use;Antioxidants/chemistry/pharmacology/*therapeutic use;Antiviral Agents/chemistry/pharmacology/*therapeutic use;COVID19/*drug therapy;Drug Repositioning/*methods/trends;Humans;SARSCoV2/*drug effects;Treatment Outcome;Virus Internalization/drug effects;DA 2021/01/14 06:00', 'SI': '', 'TI': 'Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A ', 'GR': ''}\n",
      "25 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33041814/?format=pubmed...\n",
      "{'PMID': '33041814', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19 proposed therapy;Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV2);convalescent plasma;pandemic;therapeutic challenges', 'MH': 'DA 2020/10/13 06:01', 'SI': '', 'TI': 'Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future ', 'GR': ''}\n",
      "26 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33473151/?format=pubmed...\n",
      "{'PMID': '33473151', 'PT': \"Journal Article;Research Support, N.I.H., Extramural;Research Support, NonU.S. Gov't\", 'OT': '', 'MH': 'Antiviral Agents/chemistry/*pharmacology;COVID19/*drug therapy/virology;Coronavirus 3C Proteases/*antagonists & inhibitors/chemistry/metabolism;Cysteine Proteinase Inhibitors/chemistry/*pharmacology;*Drug Discovery;Humans;Ligands;Molecular Docking Simulation;Molecular Dynamics Simulation;Protein Binding;Protein Conformation;SARSCoV2/*drug effects/enzymology;StructureActivity Relationship;Virus Replication/*drug effects;DA 2021/01/28 06:00', 'SI': '', 'TI': 'Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential ', 'GR': 'R03 AI128254/AI/NIAID NIH HHS/United States;1R03 AI12825401A1/Division of Intramural Research, National Institute of Allergy '}\n",
      "27 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33072869/?format=pubmed...\n",
      "{'PMID': '33072869', 'PT': 'Journal Article', 'OT': 'O  NNLM;COVID;Hospitalized;Mortality;SARSCoV2;Treatments', 'MH': 'DA 2020/10/20 06:01', 'SI': '', 'TI': 'Therapeutic agents tested in 238 COVID-19 hospitalized patients and their ', 'GR': ''}\n",
      "28 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32956644/?format=pubmed...\n",
      "{'PMID': '32956644', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Medications;Novel corona virus;SARSCoV2', 'MH': 'AntiInflammatory Agents/pharmacology/therapeutic use;Antiviral Agents/pharmacology/therapeutic use;COVID19;Chloroquine/analogs & derivatives/therapeutic use;Coronavirus Infections/*drug therapy/*physiopathology;DNADirected RNA Polymerases/antagonists & inhibitors;Humans;Pandemics;Pneumonia, Viral/*drug therapy/*physiopathology;DA 2020/11/06 06:00', 'SI': '', 'TI': 'A review of medications used to control and improve the signs and symptoms of ', 'GR': ''}\n",
      "29 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33035643/?format=pubmed...\n",
      "{'PMID': '33035643', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*COVID19;*HIV;*Molecular mechanisms;*Origin and taxonomy;*Potential therapeutics', 'MH': 'Antiviral Agents/pharmacology/therapeutic use;COVID19/drug therapy/*epidemiology/virology;China;Drug Repositioning;HIV/*classification/genetics/immunology;HIV Infections/drug therapy/*epidemiology/virology;Humans;Pandemics/prevention & control;Phylogeny;SARSCoV2/*classification/genetics/immunology;DA 2020/12/15 06:00', 'SI': '', 'TI': 'Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and ', 'GR': ''}\n",
      "30 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32329520/?format=pubmed...\n",
      "{'PMID': '32329520', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*COVID19;*antiinflammatory agents;*antivirals;*clinical practice;*clinical research;*immunomodulatory agents;*pharmacological treatments', 'MH': 'Animals;Antiviral Agents/*administration & dosage/adverse effects/pharmacology;Betacoronavirus/isolation & purification;COVID19;Coronavirus Infections/*drug therapy/virology;Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy/virology;SARSCoV2;DA 2020/10/28 06:00', 'SI': '', 'TI': \"Current pharmacological treatments for COVID-19: What's next?\", 'GR': ''}\n",
      "31 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32346490/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '32346490', 'PT': 'Journal Article', 'OT': 'O  NNLM;COVID19 outbreak;CoVMpro;CoVNsp12 polymerase;CoVNsp13 helicase;SARSCoV2', 'MH': 'DA 2020/04/30 06:01', 'SI': '', 'TI': 'Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal ', 'GR': ''}\n",
      "32 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32992245/?format=pubmed...\n",
      "{'PMID': '32992245', 'PT': \"Journal Article;Research Support, NonU.S. Gov't\", 'OT': 'O  NNLM;*Antiviral;*COVID19;*Coronavirus;*Repurposed drugs;*SARSCoV2', 'MH': 'Antiviral Agents/chemistry/*therapeutic use;COVID19/immunology/*therapy;COVID19 Vaccines/*immunology;*Drug Repositioning;Humans;SARSCoV2/*drug effects/immunology;DA 2020/12/22 06:00', 'SI': '', 'TI': 'COVID-19 therapy: What weapons do we bring into battle?', 'GR': ''}\n",
      "33 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32880078/?format=pubmed...\n",
      "{'PMID': '32880078', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Computational;Coronavirus;Drug;SARSCoV2;Vaccine', 'MH': 'Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/virology;Computational Biology/methods;Drug Discovery/methods;Drug Repositioning/methods;Humans;Pandemics/prevention & control;SARSCoV2/*drug effects;DA 2021/02/18 06:00', 'SI': '', 'TI': 'Therapeutics for COVID-19: from computation to practices-where we are, where we are ', 'GR': ''}\n",
      "34 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32838187/?format=pubmed...\n",
      "{'PMID': '32838187', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Diagnosis;Lopinavir/ritonavir;Novel coronavirus pneumonia;Treatment', 'MH': 'DA 2020/08/25 06:00', 'SI': '', 'TI': 'Protease Inhibitor Use in COVID-19.', 'GR': ''}\n",
      "35 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32322397/?format=pubmed...\n",
      "{'PMID': '32322397', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Azithromycin;COVID19;coronavirus;hydroxychloroquine;ivermectin', 'MH': 'DA 2020/04/24 06:01', 'SI': '', 'TI': 'Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting ', 'GR': ''}\n",
      "36 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32748244/?format=pubmed...\n",
      "{'PMID': '32748244', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;diagnosis;pandemic;public health;treatment strategies', 'MH': 'Antiviral Agents/therapeutic use;*Betacoronavirus;COVID19;Coronavirus Infections/*diagnosis/*therapy;Humans;Immunization, Passive/trends;Nucleic Acid Amplification Techniques/methods/trends;Pandemics/*prevention & control;Pneumonia, Viral/*diagnosis/*therapy;RealTime Polymerase Chain Reaction/methods/trends;SARSCoV2;DA 2020/08/11 06:00', 'SI': '', 'TI': 'Diagnostic and Treatment Strategies for COVID-19.', 'GR': ''}\n",
      "37 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32854988/?format=pubmed...\n",
      "{'PMID': '32854988', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*ARDSCoV2;*COVID19;*ICU;*SARSCoV2;*Tratamiento;*Treatment;*UCI', 'MH': 'Adenosine Monophosphate/analogs & derivatives/therapeutic use;Adrenal Cortex Hormones/therapeutic use;Alanine/analogs & derivatives/therapeutic use;Antibodies, Monoclonal/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Anticoagulants/therapeutic use;Antiviral Agents/therapeutic use;Azithromycin/therapeutic use;COVID19/*drug therapy/therapy;Disease Progression;Humans;Hydroxychloroquine/therapeutic use;Immunization, Passive;Immunoglobulins, Intravenous/therapeutic use;Immunomodulation;Interferonbeta/therapeutic use;Interleukin 1 Receptor Antagonist Protein/therapeutic use;Lopinavir/therapeutic use;Protein Kinase Inhibitors/therapeutic use;Pyrazoles/therapeutic use;Ritonavir/therapeutic use;*SARSCoV2;DA 2021/03/11 06:00', 'SI': '', 'TI': 'Pharmacological treatment of COVID-19: Narrative review of the Working Group in ', 'GR': ''}\n",
      "38 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32777212/?format=pubmed...\n",
      "{'PMID': '32777212', 'PT': 'Journal Article', 'OT': 'O  NNLM;Anticoagulants;Antivirals;Chloroquine;Dexamethasone;Ivermectin', 'MH': 'AntiInflammatory Agents/therapeutic use;Antimalarials/therapeutic use;Antiviral Agents/*therapeutic use;COVID19;Coronavirus Infections/*drug therapy;Dexamethasone/therapeutic use;Humans;In Vitro Techniques;Pandemics;Pneumonia, Viral/*drug therapy;DA 2020/11/06 06:00', 'SI': '', 'TI': 'What to expect from different drugs used in the treatment of COVID-19: A study on ', 'GR': ''}\n",
      "39 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33389724/?format=pubmed...\n",
      "{'PMID': '33389724', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiviral;COVID19;Drug repurposing;SARSCoV2;Target proteins', 'MH': 'DA 2021/01/04 06:00', 'SI': '', 'TI': 'SARS-CoV-2 therapeutics: how far do we stand from a remedy?', 'GR': ''}\n",
      "40 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33530467/?format=pubmed...\n",
      "{'PMID': '33530467', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;clinical trials;drug repurposing;in silico;in vitro;in vivo;multitargeting;natural products', 'MH': '*Antiviral Agents/chemistry/therapeutic use;COVID19/*drug therapy/epidemiology/metabolism;*Drug Delivery Systems;Humans;Pandemics;*SARSCoV2/chemistry/metabolism;DA 2021/02/09 06:00', 'SI': '', 'TI': 'Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable ', 'GR': ''}\n",
      "41 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32358833/?format=pubmed...\n",
      "{'PMID': '32358833', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': '', 'MH': 'Animals;Antiviral Agents/*administration & dosage/pharmacology;Betacoronavirus/isolation & purification;COVID19;Coronavirus Infections/*drug therapy/virology;Drug Development;Drug Discovery;Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy/virology;SARSCoV2;DA 2020/10/28 06:00', 'SI': '', 'TI': 'A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and ', 'GR': 'Award Ref TG/18/4/33770/AF03 British Heart Foundation Translational/International;107715/Z/15/Z/WT_/Wellcome Trust/United Kingdom'}\n",
      "42 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33397429/?format=pubmed...\n",
      "{'PMID': '33397429', 'PT': 'Clinical Trial Protocol;Letter', 'OT': 'O  NNLM;COVID19;Clinical symptoms;Hospitalization Mechanical ventilation;Ivermectin;Protocol;Randomized controlled trial', 'MH': 'Administration, Oral;Adult;Antiviral Agents/*administration & dosage/adverse effects;COVID19/diagnosis/*drug therapy/virology;Clinical Trials, Phase III as Topic;Drug Therapy, Combination/adverse effects/methods;Female;Humans;Hydroxychloroquine/administration & dosage/adverse effects;Intensive Care Units/statistics & numerical data;Interferon beta1a/administration & dosage/adverse effects;Iran;Ivermectin/*administration & dosage/adverse effects;Length of Stay/statistics & numerical data;Lopinavir/administration & dosage/adverse effects;Male;Randomized Controlled Trials as Topic;Ritonavir/administration & dosage/adverse effects;SARSCoV2/drug effects/*isolation & purification;Severity of Illness Index;DA 2021/01/13 06:00', 'SI': '', 'TI': 'The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A ', 'GR': '990238/Hormozgan University of Medical Sciences/'}\n",
      "43 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32499154/?format=pubmed...\n",
      "{'PMID': '32499154', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*Human coronavirus;*SARSCoV2;*Structure;*Therapy;*Treatments;*Virus', 'MH': 'Animals;Betacoronavirus/drug effects/physiology;COVID19;Clinical Trials as Topic;Coronavirus Infections/drug therapy/*epidemiology/*therapy;Genome, Viral;Global Health;HostPathogen Interactions;Humans;Ligands;Pandemics;Pneumonia, Viral/*epidemiology/*therapy;Risk;SARSCoV2;Virus Replication;DA 2020/09/29 06:00', 'SI': '', 'TI': 'Covid-19 Pandemic and Current Medical Interventions.', 'GR': ''}\n",
      "44 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32423024/?format=pubmed...\n",
      "{'PMID': '32423024', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;ACE2;COVID19;SARSCoV2;TMPRSS2;baricitinib;chloroquine;favipiravir;interferons;lopinavir;remdesivir', 'MH': 'DA 2020/05/20 06:01', 'SI': '', 'TI': 'The Rationale for Potential Pharmacotherapy of COVID-19.', 'GR': ''}\n",
      "45 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32708302/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '32708302', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;NFκB pathway;anticancer;antiinflammatory;autoimmune disease;clinical trials;small molecules', 'MH': 'AntiInflammatory Agents/*pharmacology;Antineoplastic Agents/*pharmacology;Drug Discovery/*methods;Humans;Ikappa B Kinase/antagonists & inhibitors/*metabolism;NFkappa B/antagonists & inhibitors/*metabolism;Proteasome Inhibitors/pharmacology;Signal Transduction/*drug effects/genetics;Ubiquitination/drug effects;DA 2021/03/05 06:00', 'SI': '', 'TI': 'Small Molecule NF-κB Pathway Inhibitors in Clinic.', 'GR': 'NRFCRP17201702/National Research Foundation Singapore/'}\n",
      "46 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32391242/?format=pubmed...\n",
      "{'PMID': '32391242', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Biomarkers;COVID19;Coronavirus management algorithm;Precision medicine', 'MH': 'DA 2020/05/12 06:00', 'SI': '', 'TI': 'A Precision Medicine Approach to SARS-CoV-2 Pandemic Management.', 'GR': ''}\n",
      "47 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33058394/?format=pubmed...\n",
      "{'PMID': '33058394', 'PT': 'Journal Article', 'OT': 'O  NNLM;COVID19;SARSCoV2;antiviral drugs;therapeutic targets', 'MH': 'Antiviral Agents/*pharmacology/therapeutic use;COVID19/*drug therapy/immunology/virology;Humans;Immune System Phenomena/*drug effects;SARSCoV2/*drug effects/immunology/metabolism/pathogenicity;DA 2020/12/19 06:00', 'SI': '', 'TI': 'SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.', 'GR': 'Finance Code 001./Coordenação de Aperfeiçoamento de Pessoal de Nível Superior/'}\n",
      "48 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33288313/?format=pubmed...\n",
      "{'PMID': '33288313', 'PT': 'Journal Article', 'OT': 'O  NNLM;Aerosol;Coronavirus;Covid19;Mouthrinses;Mouthwashes;SARSCoV2', 'MH': 'Aerosols;Antiviral Agents/therapeutic use;COVID19/prevention & control/*transmission/*virology;Dental Auxiliaries;Dentists;Disease Reservoirs/virology;Humans;In Vitro Techniques;Infectious Disease Transmission, PatienttoProfessional/*prevention & control;*Models, Biological;Mouthwashes/chemistry/*therapeutic use;Oropharynx/virology;Pandemics/prevention & control;Randomized Controlled Trials as Topic/methods;SARSCoV2/genetics/*isolation & purification/pathogenicity;Saliva/virology;*Viral Load;DA 2021/01/29 06:00', 'SI': '', 'TI': 'Can preprocedural mouthrinses reduce SARS-CoV-2 load in dental aerosols?', 'GR': ''}\n",
      "49 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33482181/?format=pubmed...\n",
      "{'PMID': '33482181', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;2019nCoV;COVID19;Drug repositioning;Outbreak;Review;SARSCoV2', 'MH': 'Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/virology;Humans;Pandemics/prevention & control;SARSCoV2/*drug effects;DA 2021/02/23 06:00', 'SI': '', 'TI': 'A review of potential suggested drugs for coronavirus disease (COVID-19) treatment.', 'GR': ''}\n",
      "50 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32848795/?format=pubmed...\n",
      "{'PMID': '32848795', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;adjunctive therapy;antivirals;therapeutics', 'MH': 'DA 2020/08/28 06:01', 'SI': '', 'TI': 'COVID-19 Therapeutic Options Under Investigation.', 'GR': ''}\n",
      "51 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33476760/?format=pubmed...\n",
      "{'PMID': '33476760', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antivirals;COVID19;Clinical trials;Immunomodulators;Prevention;SARSCoV2;Vaccines', 'MH': 'Antiviral Agents/therapeutic use;COVID19/*prevention & control;*Clinical Trials as Topic;*Drug Development;*Drug Repositioning;Humans;Immunologic Factors/therapeutic use;SARSCoV2;Vaccines/therapeutic use;DA 2021/04/24 06:00', 'SI': '', 'TI': 'Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early ', 'GR': ''}\n",
      "52 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32702077/?format=pubmed...\n",
      "{'PMID': '32702077', 'PT': 'Preprint', 'OT': '', 'MH': 'DA 2020/07/24 06:01', 'SI': '', 'TI': 'Identification of new drug treatments to combat COVID19: A signature-based approach ', 'GR': 'R01 MH107487/MH/NIMH NIH HHS/United States;R01 MH121102/MH/NIMH NIH HHS/United States'}\n",
      "53 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32878641/?format=pubmed...\n",
      "{'PMID': '32878641', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Immunotherapeutics;SARSCoV2;Therapeutics;Vaccines', 'MH': 'Antiviral Agents/*therapeutic use;Betacoronavirus;China/epidemiology;Coronavirus/*immunology;Coronavirus Infections/*drug therapy/epidemiology/*prevention & control;Humans;Pandemics/*prevention & control;SARSCoV2;Severe Acute Respiratory Syndrome/*drug therapy/epidemiology;Vaccines/*therapeutic use;DA 2020/09/10 06:00', 'SI': '', 'TI': 'SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines ', 'GR': ''}\n",
      "54 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32926918/?format=pubmed...\n",
      "{'PMID': '32926918', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Clinical trials;Pathophysiology;Pharmacotherapy;SARSCov2', 'MH': 'COVID19;Clinical Trials as Topic;Coronavirus Infections/*complications/*drug therapy;Humans;Molecular Targeted Therapy/*methods;Pandemics;Pneumonia, Viral/*complications/*drug therapy;DA 2020/10/27 06:00', 'SI': '', 'TI': 'COVID-19 associated complications and potential therapeutic targets.', 'GR': ''}\n",
      "55 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32889701/?format=pubmed...\n",
      "{'PMID': '32889701', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Coronavirus;Repurposing;SARSCoV2', 'MH': 'Animals;Antiviral Agents/pharmacology/*therapeutic use;COVID19/*drug therapy/virology;Computer Simulation;Drug Discovery/methods;*Drug Repositioning;Humans;SARSCoV2/drug effects/pathogenicity;DA 2020/12/15 06:00', 'SI': '', 'TI': 'Drug repurposing approach to fight COVID-19.', 'GR': ''}\n",
      "56 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32293834/?format=pubmed...\n",
      "{'PMID': '32293834', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*Covid19;*SarsCoV2;*antiviral', 'MH': 'Adenosine Monophosphate/analogs & derivatives;Alanine/analogs & derivatives;Amides;Antiviral Agents/*therapeutic use;Betacoronavirus;COVID19;Chloroquine;Coronavirus Infections/*drug therapy;Drug Combinations;Humans;Hydroxychloroquine;Ivermectin;Lopinavir;Pandemics;Pneumonia, Viral/*drug therapy;Pyrazines;Ritonavir;SARSCoV2;Thiazoles;DA 2020/04/23 06:00', 'SI': '', 'TI': 'Antiviral treatment of COVID-19.', 'GR': ''}\n",
      "57 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32565132/?format=pubmed...\n",
      "{'PMID': '32565132', 'PT': \"Journal Article;Research Support, N.I.H., Extramural;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*COVID19;*CRS;*HLH;*IRIS;*SARSCoV2;*cellular therapy;*cytokine release;*hyperimmune response;*immunotherapy', 'MH': 'Adrenal Cortex Hormones/therapeutic use;COVID19;Coronavirus Infections/drug therapy/*etiology/physiopathology;Cytokine Release Syndrome/etiology/therapy;Humans;Immune Reconstitution Inflammatory Syndrome/etiology/therapy;Immunization, Passive;Interleukin1/antagonists & inhibitors;Interleukin6/antagonists & inhibitors;Killer Cells, Natural/immunology;Lymphohistiocytosis, Hemophagocytic/etiology/therapy;Pandemics;Plasmapheresis;Pneumonia, Viral/*etiology/physiopathology;STAT Transcription Factors/antagonists & inhibitors;DA 2020/09/08 06:00', 'SI': '', 'TI': 'Emerging trends in COVID-19 treatment: learning from inflammatory conditions ', 'GR': 'P30 CA008748/CA/NCI NIH HHS/United States'}\n",
      "58 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32532623/?format=pubmed...\n",
      "{'PMID': '32532623', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*COVID19;*Clinical trials;*NAATs;*SARSCoV2;*Spike protein;*Vaccine', 'MH': 'Betacoronavirus/*drug effects/immunology/pathogenicity;COVID19;COVID19 Vaccines;Coronavirus/*drug effects;Coronavirus Infections/diagnosis/*drug therapy/*prevention & control/therapy;Humans;Immunization, Passive/methods;Pandemics/*prevention & control;Pneumonia, Viral/diagnosis/*drug therapy/*prevention & control;SARSCoV2;Viral Vaccines/*therapeutic use;DA 2020/10/30 06:00', 'SI': '', 'TI': 'Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.', 'GR': ''}\n",
      "59 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32734518/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '32734518', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Coronaviruses;Drug classification;Pandemic;Pharmaceutical agents;Possible treatments;SARSCoV2', 'MH': 'Animals;COVID19/*drug therapy/physiopathology/virology;Humans;Inflammation/drug therapy/physiopathology/virology;SARSCoV2/*drug effects/pathogenicity;DA 2020/12/15 06:00', 'SI': '', 'TI': 'Classification of the present pharmaceutical agents based on the possible effective ', 'GR': ''}\n",
      "60 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33493917/?format=pubmed...\n",
      "{'PMID': '33493917', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Computational docking;Drug repurposing;SARSCoV2;Vaccine', 'MH': 'Antiviral Agents/*therapeutic use;COVID19/*drug therapy/*prevention & control;*COVID19 Vaccines;Clinical Trials as Topic;Drug Repositioning;Humans;Pandemics;DA 2021/03/03 06:00', 'SI': '', 'TI': 'The growing complexity of COVID-19 drug and vaccine candidates: challenges and ', 'GR': ''}\n",
      "61 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33070079/?format=pubmed...\n",
      "{'PMID': '33070079', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiviral drugs;COVID19;Clinical trials;Drug repurposing;Monoclonal antibodies;SARSCoV2;Small molecule drugs;Vaccines', 'MH': 'Antiviral Agents/*therapeutic use;COVID19/*drug therapy/epidemiology/prevention & control/*therapy;COVID19 Vaccines/*therapeutic use;Clinical Trials as Topic;Drug Repositioning;Humans;Pandemics/prevention & control;SARSCoV2;DA 2020/12/31 06:00', 'SI': '', 'TI': 'Primed for global coronavirus pandemic: Emerging research and clinical outcome.', 'GR': ''}\n",
      "62 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33239864/?format=pubmed...\n",
      "{'PMID': '33239864', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;anticancer drugs;drugrepurposing', 'MH': 'Antineoplastic Agents/*therapeutic use;Antiviral Agents/therapeutic use;COVID19/*drug therapy;Clinical Trials as Topic;*Drug Repositioning;Humans;DA 2020/12/15 06:00', 'SI': '', 'TI': 'Repurposing Anti-Cancer Drugs for COVID-19 Treatment.', 'GR': 'P30 CA086862/CA/NCI NIH HHS/United States;T32 GM007337/GM/NIGMS NIH HHS/United States'}\n",
      "63 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32511912/?format=pubmed...\n",
      "{'PMID': '32511912', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': '', 'MH': 'Amino Acid Sequence;Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy;Drug Repositioning;Enzyme Inhibitors/therapeutic use;Humans;Immunity, Innate/drug effects;SARSCoV2/*drug effects;DA 2020/12/15 06:00', 'SI': '', 'TI': 'COVID-19: Drug Targets and Potential Treatments.', 'GR': ''}\n",
      "64 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32290293/?format=pubmed...\n",
      "{'PMID': '32290293', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;ACE2;COVID19;SARSCoV2;clinical trials;immunotherapy;pneumonia;replicase;vaccine', 'MH': 'Antiviral Agents/*therapeutic use;*Betacoronavirus/chemistry/genetics/immunology/physiology;COVID19;COVID19 Vaccines;Clinical Trials as Topic;*Coronavirus Infections/diagnosis/drug therapy/epidemiology/prevention & ;Genome, Viral;Humans;Immunization, Passive;Immunologic Factors/*therapeutic use;*Pandemics;*Pneumonia, Viral/diagnosis/epidemiology/therapy/virology;SARSCoV2;*Viral Vaccines;DA 2020/04/17 06:00', 'SI': '', 'TI': 'A Review of SARS-CoV-2 and the Ongoing Clinical Trials.', 'GR': ''}\n",
      "65 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32565599/?format=pubmed...\n",
      "{'PMID': '32565599', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*Coronavirus disease19;*drug repurposing;*pandemic;*severe acute respiratory syndromecoronavirus2', 'MH': 'Betacoronavirus/isolation & purification;COVID19;COVID19 Testing;COVID19 Vaccines;*Clinical Laboratory Techniques;Coronavirus Infections/diagnosis/drug therapy/epidemiology/prevention & ;Developing Countries;Disease Outbreaks;Drug Repositioning;Drug Therapy, Combination;Humans;India/epidemiology;Pandemics;Pneumonia, Viral/diagnosis/epidemiology/*therapy;SARSCoV2;Viral Vaccines/administration & dosage;DA 2020/07/01 06:00', 'SI': '', 'TI': 'COVID-19 pandemic: A review based on current evidence.', 'GR': ''}\n",
      "66 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33495752/?format=pubmed...\n",
      "{'PMID': '33495752', 'PT': 'Journal Article', 'OT': 'O  NNLM;Anosmia;COVID19;Hyposmia;Ivermectin;SARSCoV2', 'MH': 'DA 2021/01/27 06:01', 'SI': 'ClinicalTrials.gov/NCT04390022', 'TI': 'The effect of early treatment with ivermectin on viral load, symptoms and humoral ', 'GR': ''}\n",
      "67 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33390967/?format=pubmed...\n",
      "{'PMID': '33390967', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;antiviral;drug repurposing;prophylaxis', 'MH': 'DA 2021/01/05 06:01', 'SI': '', 'TI': 'Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review.', 'GR': ''}\n",
      "68 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32947136/?format=pubmed...\n",
      "{'PMID': '32947136', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*Coronavirus;*RNA virus;*Respiratory disease;*SARSCoV2;*SARSCoV2 inhibitors', 'MH': 'Amino Acid Sequence;Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/epidemiology;*Drug Discovery;Drug Repositioning;Humans;Pandemics;Protease Inhibitors/*therapeutic use;SARSCoV2/*drug effects;DA 2020/12/15 06:00', 'SI': '', 'TI': 'Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19.', 'GR': 'U19 AI142759/AI/NIAID NIH HHS/United States'}\n",
      "69 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33442304/?format=pubmed...\n",
      "{'PMID': '33442304', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;ARDS;SARSCoV2;chloroquine;heparin;remdesivir;steroids', 'MH': 'DA 2021/01/15 06:01', 'SI': '', 'TI': 'Experimental Pharmacotherapy for COVID-19: The Latest Advances.', 'GR': ''}\n",
      "70 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32942671/?format=pubmed...\n",
      "{'PMID': '32942671', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*COVID19;*SARSCoV2;*Zika virus;*antiviral;*dengue virus;*flavivirus;*ivermectin', 'MH': 'Animals;Antiviral Agents/*pharmacology;Betacoronavirus/*drug effects;COVID19;Cell Line;Chlorocebus aethiops;Coronavirus Infections/*drug therapy;Dengue/drug therapy;Dengue Virus/drug effects;HIV Infections/drug therapy;HIV Integrase/drug effects;HIV Integrase Inhibitors/pharmacology;HIV1/*drug effects;Humans;Ivermectin/*pharmacology;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;Vero Cells;Zika Virus/drug effects;Zika Virus Infection/drug therapy;DA 2020/09/29 06:00', 'SI': '', 'TI': 'Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?', 'GR': 'Senior Principal Research Fellowship APP1002486/APP1103050/National Health and '}\n",
      "71 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32468014/?format=pubmed...\n",
      "{'PMID': '32468014', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'Angiotensin II Type 1 Receptor Blockers/classification/therapeutic use;AngiotensinConverting Enzyme 2;Betacoronavirus/*drug effects/pathogenicity/physiology;Bromhexine/pharmacology/therapeutic use;COVID19;Chlorpromazine/pharmacology/therapeutic use;Clinical Trials as Topic/methods;Coronavirus Infections/*drug therapy/epidemiology/mortality;Diminazene/pharmacology/therapeutic use;*Drug Repositioning/methods/standards/trends;Gabexate/analogs & derivatives/pharmacology/therapeutic use;Humans;Pandemics;PeptidylDipeptidase A/chemistry/metabolism/therapeutic use;Pneumonia, Viral/*drug therapy/epidemiology/mortality;Receptor, Angiotensin, Type 1/metabolism;Recombinant Proteins/chemistry/therapeutic use;SARSCoV2;Signal Transduction/drug effects;Virus Internalization/*drug effects;DA 2020/07/02 06:00', 'SI': '', 'TI': 'Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights ', 'GR': ''}\n",
      "72 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32557011/?format=pubmed...\n",
      "{'PMID': '32557011', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Complications;Potential cardiotoxicity;SARSCoV2', 'MH': 'Antiviral Agents/*pharmacology;*COVID19/drug therapy/immunology;Cardiotoxicity/*prevention & control;Cardiovascular System/*drug effects;Humans;Immunologic Factors/*pharmacology;Risk Assessment;SARSCoV2/*drug effects;DA 2021/04/07 06:00', 'SI': '', 'TI': 'A Double-Edged Sword-Cardiovascular Concerns of Potential Anti-COVID-19 Drugs.', 'GR': ''}\n",
      "73 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33086029/?format=pubmed...\n",
      "{'PMID': '33086029', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;ACE2;ACEIs;ARBs and COVID19;RAS;SARSCoV2', 'MH': 'Angiotensin Receptor Antagonists/*therapeutic use;AngiotensinConverting Enzyme 2/metabolism;AngiotensinConverting Enzyme Inhibitors/*therapeutic use;Animals;COVID19/*drug therapy/metabolism;Humans;ProtoOncogene Proteins/metabolism;Receptors, GProteinCoupled/metabolism;*ReninAngiotensin System;SARS Virus;*SARSCoV2/physiology;Severe Acute Respiratory Syndrome;DA 2020/12/30 06:00', 'SI': '', 'TI': 'Renin-angiotensin system at the interface of COVID-19 infection.', 'GR': ''}\n",
      "74 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32718020/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '32718020', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;ACE2;COVID19;SARSCoV2;TMPRSS2;coronavirus;endocytosis;spike protein;viral entry;viral fusion', 'MH': 'Antibodies, Monoclonal/chemistry/pharmacology/therapeutic use;Antiviral Agents/chemistry/pharmacology/*therapeutic use;Betacoronavirus/drug effects/*physiology;COVID19;Clinical Trials as Topic;Coronavirus Infections/*drug therapy;Humans;Pandemics;Peptides/chemistry/pharmacology/therapeutic use;Pneumonia, Viral/*drug therapy;Polysaccharides/chemistry/pharmacology/therapeutic use;SARSCoV2;Small Molecule Libraries/chemistry/pharmacology/therapeutic use;Virus Attachment/drug effects;Virus Internalization/drug effects;DA 2020/08/13 06:00', 'SI': '', 'TI': 'Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life ', 'GR': 'SC3GM131986; P20GM103424/GM/NIGMS NIH HHS/United States'}\n",
      "75 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33071609/?format=pubmed...\n",
      "{'PMID': '33071609', 'PT': 'Editorial', 'OT': '', 'MH': 'DA 2020/10/20 06:01', 'SI': '', 'TI': 'The Covid-19, Epidemiology, Clinic and Prevention.', 'GR': ''}\n",
      "76 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32838264/?format=pubmed...\n",
      "{'PMID': '32838264', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*coronavirus disease 2019;*placenta;*pregnancy;*severe acute respiratory syndrome coronavirus 2', 'MH': 'Abnormalities, DrugInduced/etiology/*prevention & control;*Antiviral Agents/adverse effects/classification/pharmacokinetics;COVID19/*drug therapy;Compassionate Use Trials;*Drugs, Investigational/adverse effects/classification/pharmacokinetics;Female;Humans;*MaternalFetal Exchange;Pregnancy;Pregnancy Complications, Infectious/*drug therapy;SARSCoV2;DA 2020/08/25 06:01', 'SI': '', 'TI': 'Placental transfer and safety in pregnancy of medications under investigation to ', 'GR': ''}\n",
      "77 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33131530/?format=pubmed...\n",
      "{'PMID': '33131530', 'PT': 'Journal Article', 'OT': 'O  NNLM;*COVID19;*Candidate drugs;*Infection pathways;*Interactome;*Prophylaxis agents;*Proteome;*SARSCoV2;*Transcriptome', 'MH': '*Antiviral Agents/chemistry/pharmacokinetics/therapeutic use;*Betacoronavirus/genetics/metabolism;COVID19;*Coronavirus Infections/drug therapy/genetics/metabolism;*Databases, Genetic;*Drug Discovery;Humans;*Models, Biological;*Pandemics;*Pneumonia, Viral/drug therapy/genetics/metabolism;Proteomics;SARSCoV2;DA 2020/11/18 06:00', 'SI': '', 'TI': 'Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs ', 'GR': ''}\n",
      "78 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32890967/?format=pubmed...\n",
      "{'PMID': '32890967', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiinflammatory;Antiviral;COVID19;PAK1 blocker;Propolis;SARSCoV2', 'MH': 'Animals;Antiviral Agents/administration & dosage/*pharmacology;Betacoronavirus/drug effects/isolation & purification;COVID19;Coronavirus Infections/complications/*drug therapy/virology;Dietary Supplements;Functional Food;Humans;Macrophages/drug effects/immunology;Monocytes/drug effects/immunology;Pandemics;Pneumonia, Viral/complications/*drug therapy/virology;Propolis/administration & dosage/*pharmacology;SARSCoV2;DA 2020/11/11 06:00', 'SI': '', 'TI': 'Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 ', 'GR': ''}\n",
      "79 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33347311/?format=pubmed...\n",
      "{'PMID': '33347311', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*SARSCoV2;*drug;*replication process;*target', 'MH': 'AngiotensinConverting Enzyme 2/metabolism;Animals;Antiviral Agents/chemistry/*pharmacology;Basigin/metabolism;Coronavirus 3C Proteases/antagonists & inhibitors/metabolism;Coronavirus Nucleocapsid Proteins/chemistry/metabolism;Coronavirus RNADependent RNA Polymerase/metabolism;Dipeptidyl Peptidase 4/metabolism;Furin/antagonists & inhibitors/metabolism;HostPathogen Interactions/drug effects;Humans;SARSCoV2/*drug effects/pathogenicity/physiology;Serine Endopeptidases/metabolism;Small Molecule Libraries/pharmacology;Spike Glycoprotein, Coronavirus/chemistry/metabolism;Virus Replication/*drug effects;DA 2021/01/20 06:00', 'SI': '', 'TI': 'Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral ', 'GR': ''}\n",
      "80 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33123014/?format=pubmed...\n",
      "{'PMID': '33123014', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;antimicrobial therapy;coronavirus disease 2019;drug;severe acute respiratory syndrome coronavirus 2;supportive therapy;vaccine', 'MH': 'DA 2020/10/31 06:01', 'SI': '', 'TI': 'Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial ', 'GR': ''}\n",
      "81 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32993173/?format=pubmed...\n",
      "{'PMID': '32993173', 'PT': 'Journal Article;Research Support, N.I.H., Extramural;Review', 'OT': 'O  NNLM;*COVID19;*EIDD2801;*RNAdependent RNA polymerase;*SARSCoV2;*dexamethasone;*dihydroorotate dehydrogenase;*favipiravir;*main protease;*papainlike protease;*remdesivir', 'MH': 'Animals;AntiInflammatory Agents/therapeutic use;Antibodies, Monoclonal/therapeutic use;Antiviral Agents/chemistry/pharmacology/*therapeutic use;Betacoronavirus/*drug effects/physiology;COVID19;Clinical Trials as Topic;Coronavirus Infections/*drug therapy/virology;Drug Delivery Systems;Drug Development;Humans;Pandemics;Peptides/therapeutic use;Pneumonia, Viral/*drug therapy/virology;Protease Inhibitors/therapeutic use;SARSCoV2;DA 2020/11/03 06:00', 'SI': '', 'TI': 'Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the ', 'GR': 'SC3GM131986/GM/NIGMS NIH HHS/United States;P20GM103424/GM/NIGMS NIH HHS/United States'}\n",
      "82 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32773165/?format=pubmed...\n",
      "{'PMID': '32773165', 'PT': 'Journal Article', 'OT': 'O  NNLM;*COVID;*Hospitalizados;*Hospitalized;*Mortalidad;*Mortality;*SARSCoV2;*Tratamientos;*Treatments', 'MH': 'Adrenal Cortex Hormones/therapeutic use;Angiotensin II Type 1 Receptor Blockers/therapeutic use;AngiotensinConverting Enzyme Inhibitors/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Antiviral Agents/therapeutic use;Azithromycin/therapeutic use;*Betacoronavirus/drug effects;COVID19;Comorbidity;Coronavirus Infections/*drug therapy/mortality;Drug Therapy, Combination;Female;Humans;Hydroxychloroquine/therapeutic use;Inpatients/statistics & numerical data;Lopinavir/therapeutic use;Male;Pandemics;Pneumonia, Viral/*drug therapy/mortality;Proportional Hazards Models;Retrospective Studies;Ritonavir/therapeutic use;SARSCoV2;Spain;Treatment Outcome;DA 2020/11/20 06:00', 'SI': '', 'TI': 'Therapeutic agents tested in 238 COVID-19 hospitalized patients and their ', 'GR': ''}\n",
      "83 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32623267/?format=pubmed...\n",
      "{'PMID': '32623267', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Coronavirus;Pandemic;Review;SARSCoV2', 'MH': '*Betacoronavirus/genetics/immunology/physiology;COVID19;Coronavirus Infections/diagnosis/epidemiology/immunology/*virology;Genome, Viral/genetics;HIV Infections/complications;Humans;Pandemics;Pneumonia, Viral/diagnosis/epidemiology/immunology/*virology;SARSCoV2;Virus Replication;DA 2020/08/18 06:00', 'SI': '', 'TI': 'Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus ', 'GR': ''}\n",
      "84 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32661214/?format=pubmed...\n",
      "{'PMID': '32661214', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'Adrenal Cortex Hormones/*therapeutic use;AngiotensinConverting Enzyme 2;Antiviral Agents/*therapeutic use;Betacoronavirus/drug effects/immunology/pathogenicity;COVID19;Coronavirus Infections/*drug therapy/epidemiology/immunology/virology;Disease Progression;Drug Discovery;*Drug Repositioning;Gene Expression Regulation;HostPathogen Interactions/drug effects/genetics/immunology;Humans;Hydroxychloroquine/therapeutic use;Immunologic Factors/*therapeutic use;Molecular Docking Simulation;Molecular Targeted Therapy/methods;*Pandemics;PeptidylDipeptidase A/genetics/immunology;Pneumonia, Viral/*drug therapy/epidemiology/immunology/virology;SARSCoV2;Signal Transduction/genetics/immunology;Spike Glycoprotein, Coronavirus/antagonists & inhibitors/genetics/immunology;DA 2020/07/22 06:00', 'SI': '', 'TI': 'Drug targets for COVID-19 therapeutics: Ongoing global efforts.', 'GR': ''}\n",
      "85 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33029696/?format=pubmed...\n",
      "{'PMID': '33029696', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;ARDS;Cytokine storm syndrome;Herd immunity;Rheumatoid arthritis;Vaccine nationalism;Vertical transmission', 'MH': 'AngiotensinConverting Enzyme 2/*genetics;COVID19/*drug therapy/genetics/therapy/virology;China;Chloroquine/therapeutic use;Drug Repositioning/methods;Humans;Immunization, Passive/methods;*Pandemics;SARSCoV2/*genetics/pathogenicity;DA 2021/02/13 06:00', 'SI': '', 'TI': 'Role of ACE2 receptor and the landscape of treatment options from convalescent ', 'GR': 'TAR/2018/001054/Science and Engineering Research Board/'}\n",
      "86 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33072781/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '33072781', 'PT': 'Systematic Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;antivirals;clinical trials;drug development;immunomodulators;research protocols', 'MH': 'DA 2020/10/20 06:01', 'SI': '', 'TI': 'The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 ', 'GR': ''}\n",
      "87 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32474009/?format=pubmed...\n",
      "{'PMID': '32474009', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Prevention;SARSCoV2;Transmission;Treatment', 'MH': 'Adrenal Cortex Hormones/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus/*drug effects/pathogenicity;COVID19/*epidemiology/prevention & control/*therapy/transmission;COVID19 Vaccines;Clinical Trials as Topic;Coronavirus Infections/*epidemiology/prevention & control/*therapy/transmission;Drug Repositioning;Humans;Immunization, Passive/methods;Immunologic Factors/therapeutic use;Molecular Targeted Therapy/methods;*Pandemics/prevention & control;Personal Protective Equipment;Physical Distancing;Pneumonia, Viral/*epidemiology/prevention & control/*therapy/transmission;SARSCoV2;Viral Vaccines/biosynthesis;DA 2020/07/23 06:00', 'SI': '', 'TI': 'COVID-19: Transmission, prevention, and potential therapeutic opportunities.', 'GR': ''}\n",
      "88 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33199136/?format=pubmed...\n",
      "{'PMID': '33199136', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Clinical trials;Pandemic;Repurposed medicine;SARSCoV2;Vaccine', 'MH': 'DA 2020/11/18 06:00', 'SI': '', 'TI': 'In-line treatments and clinical initiatives to fight against COVID-19 outbreak.', 'GR': ''}\n",
      "89 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33264337/?format=pubmed...\n",
      "{'PMID': '33264337', 'PT': \"Journal Article;Multicenter Study;Randomized Controlled Trial;Research Support, NonU.S. Gov't\", 'OT': '', 'MH': 'Adult;COVID19/*drug therapy;Female;Humans;Hydroxychloroquine/*adverse effects/*therapeutic use;Male;Middle Aged;Retrospective Studies;*Safety;Standard of Care;Treatment Outcome;Young Adult;DA 2020/12/15 06:00', 'SI': '', 'TI': 'A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and ', 'GR': ''}\n",
      "90 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33158234/?format=pubmed...\n",
      "{'PMID': '33158234', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*Traditional Chinese Medicines;*angiotensinconverting enzyme2;*antiviral;*epidemiology', 'MH': 'Betacoronavirus;COVID19;Coronavirus Infections/*epidemiology/*therapy;Humans;Medicine, Chinese Traditional;Pandemics;Pneumonia, Viral/*epidemiology/*therapy;SARSCoV2;DA 2020/11/21 06:00', 'SI': '', 'TI': 'COVID-19 Pandemic: Epidemiology, Etiology, Conventional and Non-Conventional ', 'GR': ''}\n",
      "91 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32334062/?format=pubmed...\n",
      "{'PMID': '32334062', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*ACE2 blocker;*Antimalaria;*Antiviral: Chinese traditional medicine;*COVID19;*Immunoenhancer;*Monoclonal antibody;*Vaccine', 'MH': 'Adrenal Cortex Hormones/therapeutic use;AngiotensinConverting Enzyme 2;AntiInflammatory Agents, NonSteroidal/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Anticoagulants/therapeutic use;Antimalarials/therapeutic use;Antiviral Agents/therapeutic use;Betacoronavirus;Bevacizumab/therapeutic use;COVID19;COVID19 Vaccines;Chloroquine/therapeutic use;Coronavirus Infections/drug therapy/prevention & control/*therapy;Humans;Hydroxychloroquine/therapeutic use;Immunization, Passive;Immunoglobulins, Intravenous/therapeutic use;Immunologic Factors/therapeutic use;Interferons/therapeutic use;Janus Kinase Inhibitors/therapeutic use;Killer Cells, Natural;Medicine, Chinese Traditional;Mesenchymal Stem Cell Transplantation;Nitric Oxide/therapeutic use;Pandemics;PeptidylDipeptidase A;Pneumonia, Viral/*therapy;SARSCoV2;Spike Glycoprotein, Coronavirus;Trace Elements/therapeutic use;Viral Vaccines/therapeutic use;Vitamins/therapeutic use;Zinc/therapeutic use;DA 2020/07/03 06:00', 'SI': '', 'TI': 'Current status of potential therapeutic candidates for the COVID-19 crisis.', 'GR': ''}\n",
      "92 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32607499/?format=pubmed...\n",
      "{'PMID': '32607499', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'DA 2020/07/02 06:01', 'SI': '', 'TI': 'Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a ', 'GR': ''}\n",
      "93 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33227285/?format=pubmed...\n",
      "{'PMID': '33227285', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiviral;COVID19;Clinical trials;Immunomodulation;Nitazoxanide;SARSCoV2', 'MH': 'Antiprotozoal Agents/pharmacology;*COVID19/drug therapy/immunology;Clinical Trials as Topic;*Drug Repositioning;Humans;Immunity, Innate/drug effects;*SARSCoV2/drug effects/physiology;Thiazoles/*pharmacology;DA 2021/01/06 06:00', 'SI': '', 'TI': 'A review on possible mechanistic insights of Nitazoxanide for repurposing in ', 'GR': ''}\n",
      "94 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32603692/?format=pubmed...\n",
      "{'PMID': '32603692', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Clinical trials;Coronavirus;Pharmacological treatments;SARSCoV2;Therapies', 'MH': 'Adenosine Monophosphate/analogs & derivatives/pharmacology/therapeutic use;Adjuvants, Immunologic/*pharmacology/therapeutic use;Alanine/analogs & derivatives/pharmacology/therapeutic use;Antiviral Agents/*pharmacology/therapeutic use;Betacoronavirus/*drug effects/immunology/pathogenicity;COVID19;Clinical Trials as Topic;Coronavirus Infections/*drug therapy/epidemiology/virology;Glucocorticoids/pharmacology/therapeutic use;Heparin, LowMolecularWeight/pharmacology/therapeutic use;Humans;Hydroxychloroquine/pharmacology/therapeutic use;Immunity, Innate/drug effects;Inflammation Mediators/*pharmacology/therapeutic use;Oseltamivir/pharmacology/therapeutic use;Pandemics;Pneumonia, Viral/*drug therapy/epidemiology/virology;SARSCoV2;Treatment Outcome;DA 2020/08/08 06:00', 'SI': '', 'TI': 'Current pharmacological treatments for SARS-COV-2: A narrative review.', 'GR': ''}\n",
      "95 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33551661/?format=pubmed...\n",
      "{'PMID': '33551661', 'PT': 'Journal Article', 'OT': 'O  NNLM;COVID19;Coronavirus;Multiple sequence alignment;Saudi Arabia;Tanshinones', 'MH': 'DA 2021/02/09 06:01', 'SI': '', 'TI': 'Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a ', 'GR': ''}\n",
      "96 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32696234/?format=pubmed...\n",
      "{'PMID': '32696234', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;5fluorouracil;ACE2;ADAM17;Angiotensin receptor blockers;Antiandrogens;COVID19;Calmodulin antagonists;Camostat mesylate;Inhaled corticosteroids;Nafamostat mesylate;SARSCoV2;SERMs;TMPRSS2', 'MH': 'ADAM17 Protein/metabolism;AngiotensinConverting Enzyme 2;Betacoronavirus;COVID19;Coronavirus Infections/*drug therapy/prevention & control;Humans;Pandemics/prevention & control;PeptidylDipeptidase A/*metabolism;Pneumonia, Viral/*drug therapy/prevention & control;SARSCoV2;Serine Endopeptidases/*metabolism;DA 2020/11/26 06:00', 'SI': '', 'TI': 'Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising ', 'GR': ''}\n",
      "97 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32898468/?format=pubmed...\n",
      "{'PMID': '32898468', 'PT': 'Journal Article', 'OT': 'O  NNLM;*COVID19;*SARSCoV2;*chloroquine;*plasma therapy;*viraemia', 'MH': 'Betacoronavirus/immunology/isolation & purification;COVID19;Clinical Trials as Topic;Coronavirus Infections/immunology/pathology/*therapy/virology;Humans;*Immunization, Passive;Pandemics;Pneumonia, Viral/pathology/*therapy/virology;SARSCoV2;Severity of Illness Index;DA 2020/09/17 06:00', 'SI': '', 'TI': 'Convalescent plasma therapy: a promising coronavirus disease 2019 treatment ', 'GR': ''}\n",
      "98 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33519949/?format=pubmed...\n",
      "{'PMID': '33519949', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Coronavirus;Influenza, Pulmonary drug delivery;MERS, Nanomedicine;Nanotechnology;Nanotherapeutics;Pathophysiology;SARS, SARSCoV2', 'MH': 'DA 2021/02/02 06:01', 'SI': '', 'TI': 'Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary ', 'GR': ''}\n",
      "99 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32437797/?format=pubmed...\n",
      "{'PMID': '32437797', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Repurposing drugs;SARSCoV2;Spike proteins;Zoonotic origin', 'MH': 'Animals;Betacoronavirus/isolation & purification;COVID19;Coronavirus Infections/*epidemiology/*therapy/virology;Pandemics/prevention & control;Pneumonia, Viral/*epidemiology/*therapy/virology;SARSCoV2;Zoonoses/epidemiology/therapy/virology;DA 2020/06/23 06:00', 'SI': '', 'TI': 'The current understanding and potential therapeutic options to combat COVID-19.', 'GR': ''}\n",
      "100 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33234158/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '33234158', 'PT': 'Letter;Randomized Controlled Trial', 'OT': 'O  NNLM;COVID19;Hospitalization;Ivermectin;Protocol;Randomized controlled trial', 'MH': 'Adult;Antiparasitic Agents/administration & dosage/*therapeutic use;Argentina/epidemiology;COVID19/*drug therapy/epidemiology/virology;CaseControl Studies;DoubleBlind Method;Female;Hospitalization/statistics & numerical data;Humans;Ivermectin/administration & dosage/*therapeutic use;Male;Pandemics/prevention & control;Placebos/administration & dosage;Prospective Studies;SARSCoV2/*genetics;Time Factors;DA 2020/12/15 06:00', 'SI': 'ClinicalTrials.gov/NCT04529525', 'TI': 'Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): ', 'GR': ''}\n",
      "101 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33330858/?format=pubmed...\n",
      "{'PMID': '33330858', 'PT': 'Preprint', 'OT': '', 'MH': 'DA 2020/12/18 06:01', 'SI': '', 'TI': 'Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, ', 'GR': 'R01 AG066749/AG/NIA NIH HHS/United States;R01 LM012806/LM/NLM NIH HHS/United States'}\n",
      "102 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33096261/?format=pubmed...\n",
      "{'PMID': '33096261', 'PT': 'Editorial', 'OT': 'O  NNLM;*COVID19;*SARSCoV2;*antiinfective agents;*antiparasitic agent;*antiviral agent;*antibiotic agent', 'MH': 'Adenosine Monophosphate/analogs & derivatives/therapeutic use;Alanine/analogs & derivatives/therapeutic use;AntiBacterial Agents/therapeutic use;Antiparasitic Agents/therapeutic use;Antiviral Agents/*therapeutic use;COVID19/*drug therapy;Drug Development/*trends;*Drug Repositioning;Humans;*SARSCoV2/physiology;Virus Physiological Phenomena;DA 2020/12/29 06:00', 'SI': '', 'TI': 'Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel?', 'GR': ''}\n",
      "103 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33534108/?format=pubmed...\n",
      "{'PMID': '33534108', 'PT': 'Letter', 'OT': 'O  NNLM;*COVID19;*Doxycycline;*Drug repurposing;*Minocycline;*Neuroinflammation;*SARSCoV2 infection', 'MH': 'AntiInflammatory Agents/*administration & dosage;Antiviral Agents/administration & dosage;COVID19/*drug therapy/epidemiology/immunology;Drug Repositioning/*methods;Humans;Inflammation Mediators/antagonists & inhibitors/immunology;Mental Disorders/*drug therapy/epidemiology/immunology;Nervous System Diseases/*drug therapy/epidemiology/immunology;Tetracyclines/*administration & dosage;DA 2021/05/11 06:00', 'SI': '', 'TI': 'Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric ', 'GR': ''}\n",
      "104 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33027420/?format=pubmed...\n",
      "{'PMID': '33027420', 'PT': 'Journal Article', 'OT': '', 'MH': 'Betacoronavirus;COVID19;Coronavirus Infections/*drug therapy;*Drug Discovery;*Drug Repositioning;Humans;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;DA 2020/10/10 06:00', 'SI': '', 'TI': 'COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.', 'GR': ''}\n",
      "105 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32485970/?format=pubmed...\n",
      "{'PMID': '32485970', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;animal models;antivirals', 'MH': 'DA 2020/06/04 06:01', 'SI': '', 'TI': 'A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral ', 'GR': ''}\n",
      "106 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32580969/?format=pubmed...\n",
      "{'PMID': '32580969', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;One Health;SARSCoV2;diagnosis;emerging coronavirus;therapy;vaccines', 'MH': 'Animals;Betacoronavirus/physiology;COVID19;*Coronavirus Infections/diagnosis/epidemiology/therapy/virology;Humans;*Pandemics;*Pneumonia, Viral/diagnosis/epidemiology/therapy/virology;SARSCoV2;DA 2020/07/09 06:00', 'SI': '', 'TI': 'Coronavirus Disease 2019-COVID-19.', 'GR': ''}\n",
      "107 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33022293/?format=pubmed...\n",
      "{'PMID': '33022293', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*COVID19;*Prophylaxis;*Repurposed chemotherapy;*SARSCoV2', 'MH': 'COVID19/*prevention & control;Clinical Protocols;*Clinical Trials as Topic;Humans;*PostExposure Prophylaxis;*PreExposure Prophylaxis;SARSCoV2;DA 2021/05/25 06:00', 'SI': '', 'TI': 'Clinical trial protocols of repurposed prophylaxis for COVID-19: A review.', 'GR': ''}\n",
      "108 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33321790/?format=pubmed...\n",
      "{'PMID': '33321790', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*nuclear export inhibitors;*nuclear export sequence;*nuclear import inhibitors;*nuclear import sequence;*nuclear transport receptors;*nucleoporins;*protein intrinsic disorder;*viral infection', 'MH': 'Active Transport, Cell Nucleus;Animals;Cell Nucleus/*metabolism;Humans;Protein Stability;Viral Proteins/chemistry/*metabolism;Virus Replication;DA 2021/03/23 06:00', 'SI': '', 'TI': 'The Role of Protein Disorder in Nuclear Transport and in Its Subversion by Viruses.', 'GR': ''}\n",
      "109 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33253764/?format=pubmed...\n",
      "{'PMID': '33253764', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Biologics;Covid19;Drug design;Food and nutrients;Natural products;Repurposed drugs;SARSCoV2;Vaccines', 'MH': 'Antiviral Agents/*pharmacology;Biological Products;COVID19/*drug therapy;Drug Design;Drug Discovery;Humans;Pandemics;SARSCoV2/chemistry/*drug effects/ultrastructure;DA 2021/01/08 06:00', 'SI': '', 'TI': \"Exploring the magic bullets to identify Achilles' heel in SARS-CoV-2: Delving deeper \", 'GR': ''}\n",
      "110 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33133697/?format=pubmed...\n",
      "{'PMID': '33133697', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'DA 2020/11/03 06:01', 'SI': '', 'TI': 'Stopping the COVID-19 Pandemic: A Review on the Advances of Diagnosis, Treatment, ', 'GR': ''}\n",
      "111 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33341233/?format=pubmed...\n",
      "{'PMID': '33341233', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*Antiviral;*COVID19;*Dengue virus;*Ivermectin;*SARSCoV2;*Zika virus', 'MH': 'Antiparasitic Agents/*pharmacology/therapeutic use;Antiviral Agents/*pharmacology/therapeutic use;COVID19/*drug therapy;Humans;Ivermectin/*pharmacology/therapeutic use;SARSCoV2/*drug effects;alpha Karyopherins/antagonists & inhibitors;DA 2021/03/09 06:00', 'SI': '', 'TI': 'The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?', 'GR': ''}\n",
      "112 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32395418/?format=pubmed...\n",
      "{'PMID': '32395418', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Anakinra;Azithromycin;COVID19;Chloroquine;Convalescent plasma;Epoprostenol;Favipiravir;Hydroxychloroquine;Lopinavir;Methylprednisolone;Nitric oxide;Oseltamivir;Remdesivir;SARCoV2;Sarilumab;Sirolimus;Tocilizumab;Traditional Chinese Medicine;Umifenovir;Vitamin C', 'MH': 'DA 2020/05/13 06:00', 'SI': '', 'TI': 'An Update on Current Therapeutic Drugs Treating COVID-19.', 'GR': ''}\n",
      "113 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32710969/?format=pubmed...\n",
      "{'PMID': '32710969', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': 'O  NNLM;*Antiviral agents;*COVID19;*Coronavirus;*Cytokine storm;*Drug repositioning;*SARSCoV2', 'MH': 'Animals;Antiviral Agents/*pharmacology/therapeutic use;Betacoronavirus/*drug effects;COVID19;Cardiovascular Diseases/drug therapy/virology;*Clinical Trials as Topic;Coronavirus Infections/complications/*drug therapy;Cytokines/metabolism;*Drug Repositioning;Humans;Outcome and Process Assessment, Health Care;Pandemics;Pneumonia, Viral/complications/*drug therapy;SARSCoV2;DA 2020/11/18 06:00', 'SI': '', 'TI': 'Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with ', 'GR': ''}\n",
      "114 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33348292/?format=pubmed...\n",
      "{'PMID': '33348292', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiviral;COVID19;Immune system;Interferon;Pandemic;Severe acute respiratory syndrome coronavirus 2', 'MH': 'Animals;Antiviral Agents/*pharmacology/*therapeutic use;COVID19/*drug therapy/virology;Humans;Interferon Type I/*pharmacology/*therapeutic use;Pandemics/prevention & control;SARSCoV2/*drug effects;DA 2021/02/03 06:00', 'SI': '', 'TI': 'Interferon-inducer antivirals: Potential candidates to combat COVID-19.', 'GR': ''}\n",
      "115 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33519133/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '33519133', 'PT': 'Journal Article', 'OT': 'O  NNLM;Covid 19;Siddha strategy;accelerated recovery;synergistic effect', 'MH': 'DA 2021/02/02 06:00', 'SI': '', 'TI': 'An Open Clinical Evaluation Of Selected Siddha Regimen In Expediting The Management ', 'GR': ''}\n",
      "116 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33227708/?format=pubmed...\n",
      "{'PMID': '33227708', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Azithromycin;COVID19;Chloroquine/hydroxychloroquine;Interferons;Treatment;Vaccine', 'MH': 'Antiviral Agents/*therapeutic use;Azithromycin/*therapeutic use;COVID19/*prevention & control;COVID19 Vaccines/*therapeutic use;Chloroquine/*therapeutic use;Humans;Hydroxychloroquine/therapeutic use;Interferons/*therapeutic use;Treatment Outcome;DA 2021/01/01 06:00', 'SI': '', 'TI': 'Prevention and treatment of COVID-19: Focus on interferons, ', 'GR': ''}\n",
      "117 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33014380/?format=pubmed...\n",
      "{'PMID': '33014380', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;2019nCoV;Coronavirus 2019;WHO;drugs;global tally;severe acute respiratory syndrome coronavirus 2', 'MH': 'DA 2020/10/06 06:01', 'SI': '', 'TI': 'Diagnostic approaches and potential therapeutic options for coronavirus disease ', 'GR': ''}\n",
      "118 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32935090/?format=pubmed...\n",
      "{'PMID': '32935090', 'PT': 'Preprint', 'OT': '', 'MH': 'DA 2020/09/17 06:01', 'SI': '', 'TI': 'Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or ', 'GR': ''}\n",
      "119 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32654267/?format=pubmed...\n",
      "{'PMID': '32654267', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*COVID19 pneumonia;*animal models and immunotherapy;*diagnosis;*entry mechanism;*possible vaccines;*symptoms;*transmission', 'MH': 'Animals;Antiviral Agents/therapeutic use;COVID19/*pathology/prevention & control/therapy/transmission;Humans;*Immunotherapy;Middle East Respiratory Syndrome Coronavirus/genetics/isolation & ;Models, Animal;Respiratory Tract Infections/*pathology/transmission/virology;SARSCoV2/genetics/isolation & purification/pathogenicity;Viral Vaccines/*immunology;DA 2020/12/15 06:00', 'SI': '', 'TI': 'The recent challenges of highly contagious COVID-19, causing respiratory infections: ', 'GR': ''}\n",
      "120 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32569708/?format=pubmed...\n",
      "{'PMID': '32569708', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*Baricitinib;*COVID19;*Coagulation;*Coronavirus;*Dexamethasone;*Drugs;*Eculizumab;*Emapalumab;*Inflammation;*Remdesivir;*Ruxolitinib;*SARSCoV1;*SARSCoV2;*Therapies;*Tocilizumab;*Treatment', 'MH': 'Adenosine Monophosphate/analogs & derivatives/therapeutic use;Alanine/analogs & derivatives/therapeutic use;AntiInflammatory Agents/*therapeutic use;Antibodies, Monoclonal/therapeutic use;Antibodies, Monoclonal, Humanized/therapeutic use;Antibodies, Neutralizing/therapeutic use;Anticoagulants/*therapeutic use;Antiviral Agents/*therapeutic use;Azetidines/therapeutic use;Betacoronavirus/*drug effects/immunology;COVID19;Coronavirus Infections/*drug therapy/virology;Cytokine Release Syndrome/*drug therapy/virology;Disseminated Intravascular Coagulation/*drug therapy/virology;Drug Combinations;Heparin/therapeutic use;Humans;Hydroxychloroquine/therapeutic use;Inflammation;Interleukin 1 Receptor Antagonist Protein/therapeutic use;Lopinavir/therapeutic use;Pandemics;Pneumonia, Viral/*drug therapy/virology;Ritonavir/therapeutic use;SARSCoV2;Sulfonamides/therapeutic use;DA 2020/09/09 06:00', 'SI': '', 'TI': 'COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. ', 'GR': ''}\n",
      "121 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33551672/?format=pubmed...\n",
      "{'PMID': '33551672', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Batlike CoV;In silico analyses;MERSCoV;Pangolin CoV;SARSCoV;nCoV', 'MH': 'DA 2021/02/09 06:00', 'SI': '', 'TI': 'The COVID-19 puzzle: a global nightmare.', 'GR': ''}\n",
      "122 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33249292/?format=pubmed...\n",
      "{'PMID': '33249292', 'PT': 'Letter', 'OT': '', 'MH': 'DA 2020/11/30 06:00', 'SI': '', 'TI': 'Repurposing medications.', 'GR': ''}\n",
      "123 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32397911/?format=pubmed...\n",
      "{'PMID': '32397911', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*COVID19;*SARSCoV2;*infection;*repurposed therapies;*vaccine;*viruses', 'MH': 'Antiviral Agents/therapeutic use;*Betacoronavirus/genetics;COVID19;COVID19 Testing;COVID19 Vaccines;Clinical Laboratory Techniques;Coronavirus/genetics;*Coronavirus Infections/diagnosis/drug ;Disease Progression;Humans;*Pandemics/prevention & control;*Pneumonia, Viral/diagnosis/epidemiology/prevention & control/therapy;RNA, Viral;SARSCoV2;*Viral Vaccines/genetics/immunology;DA 2020/05/23 06:00', 'SI': '', 'TI': 'COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and ', 'GR': ''}\n",
      "124 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33542677/?format=pubmed...\n",
      "{'PMID': '33542677', 'PT': 'Journal Article', 'OT': '', 'MH': 'DA 2021/02/06 06:01', 'SI': '', 'TI': 'Ivermectin: Panacea or true promise for COVID-19.', 'GR': ''}\n",
      "125 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32441741/?format=pubmed...\n",
      "{'PMID': '32441741', 'PT': 'Comment;Journal Article', 'OT': '', 'MH': 'Betacoronavirus;COVID19;Coronavirus Infections;Edetic Acid;Expert Testimony;Humans;Immunosuppression;*Kidney Transplantation;Pandemics;Pneumonia, Viral;SARSCoV2;Transplant Recipients;DA 2020/06/18 06:00', 'SI': '', 'TI': 'How should I manage immunosuppression in a kidney transplant patient with COVID-19? ', 'GR': ''}\n",
      "126 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33486202/?format=pubmed...\n",
      "{'PMID': '33486202', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Angiotensinconverting enzyme 2;COVID19;Main and papainlike proteases;RNAdependentRNApolymerase;Repurposing and de novo strategies;Spike protein', 'MH': 'Antiviral Agents/*pharmacology;*COVID19/drug therapy/epidemiology;Drug Development/methods;Drug Repositioning/methods;Humans;*SARSCoV2/drug effects/physiology;Treatment Outcome;Viral Proteins/antagonists & inhibitors/genetics;Virus Internalization/drug effects;DA 2021/04/07 06:00', 'SI': '', 'TI': 'Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the ', 'GR': ''}\n",
      "127 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32616710/?format=pubmed...\n",
      "{'PMID': '32616710', 'PT': \"Journal Article;Research Support, NonU.S. Gov't;Review\", 'OT': '', 'MH': 'DA 2020/07/04 06:00', 'SI': '', 'TI': 'Overcoming cancer therapeutic bottleneck by drug repurposing.', 'GR': ''}\n",
      "128 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32837982/?format=pubmed...\n",
      "{'PMID': '32837982', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Chloroquine;Coronavirus;Famotidine;Ivermectin;Nicotine;Remdesivir;SARSCov2', 'MH': 'DA 2020/08/25 06:01', 'SI': '', 'TI': 'Known drugs and small molecules in the battle for COVID-19 treatment.', 'GR': ''}\n",
      "129 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32693298/?format=pubmed...\n",
      "{'PMID': '32693298', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Antiviral drugs;Bioactivity scores;COVID19;In silico ADMET properties;Lipinski’s parameters;SARSCoV2', 'MH': 'Animals;Antiviral Agents/pharmacokinetics/*therapeutic use;Betacoronavirus/*drug effects;Biological Availability;COVID19;COVID19 Vaccines;Coronavirus Infections/*drug therapy/prevention & control;Drug Combinations;Humans;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;Viral Vaccines;DA 2020/09/25 06:00', 'SI': '', 'TI': 'COVID-19 treatment: Much research and testing, but far, few magic bullets against ', 'GR': ''}\n",
      "130 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32817953/?format=pubmed...\n",
      "{'PMID': '32817953', 'PT': 'Preprint', 'OT': '', 'MH': 'DA 2020/08/21 06:01', 'SI': '', 'TI': 'Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in ', 'GR': 'R35 GM119617/GM/NIGMS NIH HHS/United States'}\n",
      "131 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33123144/?format=pubmed...\n",
      "{'PMID': '33123144', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;*ACE2;*COVID19;*EMMPRIN;*SARSCoV2;*monoclonal antibodies;*nonstructural protein;*remdesivir;*spike receptor', 'MH': 'Adenosine Monophosphate/analogs & derivatives/therapeutic use;Alanine/analogs & derivatives/therapeutic use;AngiotensinConverting Enzyme 2;Antibodies, Monoclonal/therapeutic use;Antibodies, Viral/therapeutic use;Antiviral Agents/*therapeutic use;Betacoronavirus/*drug effects/genetics/immunology;COVID19;COVID19 Testing;Clinical Laboratory Techniques/*methods;*Coronavirus Infections/diagnosis/pathology/therapy;Disease Reservoirs/virology;Drug Repositioning/methods;Humans;Immunoenzyme Techniques;Immunotherapy;*Pandemics;PeptidylDipeptidase A/metabolism;*Pneumonia, Viral/diagnosis/pathology/therapy;Receptors, Virus/metabolism;Reverse Transcriptase Polymerase Chain Reaction;SARSCoV2;Serologic Tests/methods;Spike Glycoprotein, Coronavirus/metabolism;DA 2020/11/11 06:00', 'SI': '', 'TI': 'SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.', 'GR': ''}\n",
      "132 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33041830/?format=pubmed...\n",
      "{'PMID': '33041830', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;antiinflammatory;antiviral;coronavirus disease 2019;drug repurposing;immunotherapy;pathophysiology;severe acute respiratory syndrome coronavirus 2', 'MH': 'DA 2020/10/13 06:01', 'SI': '', 'TI': 'Pathophysiology and Potential Therapeutic Candidates for COVID-19: A Poorly ', 'GR': ''}\n",
      "133 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32472459/?format=pubmed...\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'PMID': '32472459', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;Algorithm;COVID19;Management;SarsCoV2', 'MH': 'Algorithms;*Antiviral Agents/immunology/pharmacology;Betacoronavirus/isolation & purification;COVID19;COVID19 Testing;Clinical Laboratory Techniques/*methods;*Coronavirus Infections/diagnosis/drug therapy/epidemiology/immunology/therapy;Critical Pathways;*Cytokine Release Syndrome/diagnosis/drug therapy/etiology;Humans;*Pandemics;Patient Care Team/*organization & administration;*Pneumonia, Viral/epidemiology/immunology/therapy;SARSCoV2;DA 2020/06/25 06:00', 'SI': '', 'TI': 'Treatment algorithm for COVID-19: a multidisciplinary point of view.', 'GR': ''}\n",
      "134 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32987852/?format=pubmed...\n",
      "{'PMID': '32987852', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;SARSCoV2;immune response;inflammation', 'MH': 'DA 2020/09/30 06:01', 'SI': '', 'TI': 'SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic ', 'GR': '13SOL/Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, '}\n",
      "135 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32864299/?format=pubmed...\n",
      "{'PMID': '32864299', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Coronavirus;Hydroxychloroquine;Pandemic;QT prolongation;SARSCoV2', 'MH': 'DA 2020/08/31 06:00', 'SI': '', 'TI': 'Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.', 'GR': ''}\n",
      "136 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/32433345/?format=pubmed...\n",
      "{'PMID': '32433345', 'PT': 'Journal Article;Review', 'OT': '', 'MH': 'Active Transport, Cell Nucleus/drug effects;Antibodies, Monoclonal/therapeutic use;Antiviral Agents/*therapeutic use;*Betacoronavirus/genetics;COVID19;Coronavirus Infections/*drug therapy;*Drug Development;Genome, Viral;Humans;Killer Cells, Natural/immunology;Pandemics;Pneumonia, Viral/*drug therapy;SARSCoV2;DA 2020/09/01 06:00', 'SI': '', 'TI': 'The pharmacological development of direct acting agents for emerging needed therapy ', 'GR': ''}\n",
      "137 row added!\n",
      "processing https://pubmed.ncbi.nlm.nih.gov/33065092/?format=pubmed...\n",
      "{'PMID': '33065092', 'PT': 'Journal Article;Review', 'OT': 'O  NNLM;COVID19;Convalescent plasma therapy and mesenchymal stem cell therapy;Coronavirus;Drug repurposing;SARSCOV2;Vaccines', 'MH': 'Animals;Antiviral Agents/*therapeutic use;COVID19/*drug therapy/*epidemiology;Humans;*Pandemics;*SARSCoV2;DA 2020/12/29 06:00', 'SI': '', 'TI': 'Pharmacological insight into potential therapeutic agents for the deadly Covid-19 ', 'GR': ''}\n",
      "138 row added!\n"
     ]
    }
   ],
   "source": [
    "#2. for each PMID in list, find the PMID, PT, OT and MH info from web and save to a dataframe\n",
    "\n",
    "def page_content_body(URL):\n",
    "    '''give an URL, will return the text of the body tag'''\n",
    "    response = requests.get(URL)\n",
    "    page = response.text\n",
    "    soup = BeautifulSoup(page)\n",
    "    content = soup.body.find('div', attrs={'class':'article-page'}).text\n",
    "    return content\n",
    "\n",
    "def create_new_row(content):\n",
    "    '''give the content of page body. Creat a new row for the dataframe\n",
    "       a new row includes PMID, PT, OT, MH, GR,SI, TI data extracted from the page'''\n",
    "    content_list = content.splitlines()\n",
    "    PT_list = []\n",
    "    OT_list = []\n",
    "    MH_list = []\n",
    "    GR_list = []\n",
    "    SI_list = []\n",
    "    for line in content_list:\n",
    "        if line.startswith('PMID'):\n",
    "            PMID = line.replace(r'PMID','').replace('-','').lstrip()\n",
    "        if line.startswith('TI'):\n",
    "            TI = line.replace(r'TI  - ','')\n",
    "        if line.startswith('PT'):\n",
    "            PT = line.replace(r'PT','').replace('-','').lstrip()\n",
    "            PT_list.append(PT)\n",
    "        if line.startswith('OT'):\n",
    "            OT = line.replace(r'OT','').replace('-','').lstrip()\n",
    "            OT_list.append(OT)\n",
    "        if line.startswith('MH'):\n",
    "            MH = line.replace(r'MH','').replace('-','').lstrip()\n",
    "            MH_list.append(MH)\n",
    "        if line.startswith('GR'):\n",
    "            GR = line.replace(r'GR','').replace('-','').lstrip()\n",
    "            GR_list.append(GR)\n",
    "        if line.startswith('SI'):\n",
    "            SI = line.replace(r'SI','').replace('-','').lstrip()\n",
    "            SI_list.append(SI)\n",
    "\n",
    "    PT_list_str = ';'.join(PT_list)\n",
    "    OT_list_str = ';'.join(OT_list)\n",
    "    MH_list_str = ';'.join(MH_list)\n",
    "    GR_list_str = ';'.join(GR_list)\n",
    "    SI_list_str = ';'.join(SI_list)\n",
    "\n",
    "    new_row = {'PMID':PMID, 'PT':PT_list_str, 'OT':OT_list_str, 'MH':MH_list_str, 'SI':SI_list_str, 'TI':TI,'GR':GR_list_str}\n",
    "    return new_row\n",
    "    \n",
    "Base_URL = \"https://pubmed.ncbi.nlm.nih.gov/\"\n",
    "PM_terms_df = pd.DataFrame(columns = ['PMID', 'PT', 'OT','MH','SI','TI','GR'])\n",
    "\n",
    "for x in range(len(PMID_list_uni)):\n",
    "    PMID = str(PMID_list_uni[x].replace('PMID:',''))\n",
    "    pagelink = Base_URL+PMID+\"/?format=pubmed\"\n",
    "    print(\"processing \"+pagelink+\"...\")\n",
    "    content = page_content_body(pagelink)\n",
    "    new_row = create_new_row(content)\n",
    "    print(new_row)\n",
    "    PM_terms_df = PM_terms_df.append(new_row, ignore_index=True)\n",
    "    n=x+1\n",
    "    print(str(n)+\" row added!\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PMID</th>\n",
       "      <th>PT</th>\n",
       "      <th>OT</th>\n",
       "      <th>MH</th>\n",
       "      <th>SI</th>\n",
       "      <th>TI</th>\n",
       "      <th>GR</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>32497632</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td></td>\n",
       "      <td>Aminoquinolines/therapeutic use;AntiBacterial ...</td>\n",
       "      <td></td>\n",
       "      <td>Potential therapeutic targets for combating SA...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>32560227</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td>O  NNLM;COVID19;SARSCoV2;coronavirus;therapies...</td>\n",
       "      <td>DA 2020/06/21 06:01</td>\n",
       "      <td></td>\n",
       "      <td>Vaccines and Therapies in Development for SARS...</td>\n",
       "      <td>R01AI13976802/National Institute of Allergy an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>32916249</td>\n",
       "      <td>Editorial</td>\n",
       "      <td>O  NNLM;SARSCoV2;control;diagnostics;hygiene;t...</td>\n",
       "      <td>COVID19/diagnosis/drug therapy/*prevention &amp; c...</td>\n",
       "      <td></td>\n",
       "      <td>Integrated control of COVID-19 in resource-poo...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>32784499</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td>O  NNLM;COVID19;SARSCoV2;antiviral;coronavirus...</td>\n",
       "      <td>DA 2020/08/14 06:01</td>\n",
       "      <td></td>\n",
       "      <td>Emerging Therapeutic Modalities against COVID-19.</td>\n",
       "      <td>1R01CA24119401A1/NH/NIH HHS/United States;1R01...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>32871201</td>\n",
       "      <td>Journal Article;Research Support, N.I.H., Extr...</td>\n",
       "      <td>O  NNLM;*Bioinspired materials;*Drug delivery;...</td>\n",
       "      <td>DA 2020/09/02 06:00</td>\n",
       "      <td></td>\n",
       "      <td>Recent trends in protein and peptide-based bio...</td>\n",
       "      <td>R35 GM127042/GM/NIGMS NIH HHS/United States;R2...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>32472459</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td>O  NNLM;Algorithm;COVID19;Management;SarsCoV2</td>\n",
       "      <td>Algorithms;*Antiviral Agents/immunology/pharma...</td>\n",
       "      <td></td>\n",
       "      <td>Treatment algorithm for COVID-19: a multidisci...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>32987852</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td>O  NNLM;COVID19;SARSCoV2;immune response;infla...</td>\n",
       "      <td>DA 2020/09/30 06:01</td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2: From Structure to Pathology, Host ...</td>\n",
       "      <td>13SOL/Unitatea Executiva pentru Finantarea Inv...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>32864299</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td>O  NNLM;COVID19;Coronavirus;Hydroxychloroquine...</td>\n",
       "      <td>DA 2020/08/31 06:00</td>\n",
       "      <td></td>\n",
       "      <td>Hydroxychloroquine in COVID-19: Potential Mech...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>32433345</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td></td>\n",
       "      <td>Active Transport, Cell Nucleus/drug effects;An...</td>\n",
       "      <td></td>\n",
       "      <td>The pharmacological development of direct acti...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>33065092</td>\n",
       "      <td>Journal Article;Review</td>\n",
       "      <td>O  NNLM;COVID19;Convalescent plasma therapy an...</td>\n",
       "      <td>Animals;Antiviral Agents/*therapeutic use;COVI...</td>\n",
       "      <td></td>\n",
       "      <td>Pharmacological insight into potential therape...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>138 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "         PMID                                                 PT  \\\n",
       "0    32497632                             Journal Article;Review   \n",
       "1    32560227                             Journal Article;Review   \n",
       "2    32916249                                          Editorial   \n",
       "3    32784499                             Journal Article;Review   \n",
       "4    32871201  Journal Article;Research Support, N.I.H., Extr...   \n",
       "..        ...                                                ...   \n",
       "133  32472459                             Journal Article;Review   \n",
       "134  32987852                             Journal Article;Review   \n",
       "135  32864299                             Journal Article;Review   \n",
       "136  32433345                             Journal Article;Review   \n",
       "137  33065092                             Journal Article;Review   \n",
       "\n",
       "                                                    OT  \\\n",
       "0                                                        \n",
       "1    O  NNLM;COVID19;SARSCoV2;coronavirus;therapies...   \n",
       "2    O  NNLM;SARSCoV2;control;diagnostics;hygiene;t...   \n",
       "3    O  NNLM;COVID19;SARSCoV2;antiviral;coronavirus...   \n",
       "4    O  NNLM;*Bioinspired materials;*Drug delivery;...   \n",
       "..                                                 ...   \n",
       "133      O  NNLM;Algorithm;COVID19;Management;SarsCoV2   \n",
       "134  O  NNLM;COVID19;SARSCoV2;immune response;infla...   \n",
       "135  O  NNLM;COVID19;Coronavirus;Hydroxychloroquine...   \n",
       "136                                                      \n",
       "137  O  NNLM;COVID19;Convalescent plasma therapy an...   \n",
       "\n",
       "                                                    MH SI  \\\n",
       "0    Aminoquinolines/therapeutic use;AntiBacterial ...      \n",
       "1                                  DA 2020/06/21 06:01      \n",
       "2    COVID19/diagnosis/drug therapy/*prevention & c...      \n",
       "3                                  DA 2020/08/14 06:01      \n",
       "4                                  DA 2020/09/02 06:00      \n",
       "..                                                 ... ..   \n",
       "133  Algorithms;*Antiviral Agents/immunology/pharma...      \n",
       "134                                DA 2020/09/30 06:01      \n",
       "135                                DA 2020/08/31 06:00      \n",
       "136  Active Transport, Cell Nucleus/drug effects;An...      \n",
       "137  Animals;Antiviral Agents/*therapeutic use;COVI...      \n",
       "\n",
       "                                                    TI  \\\n",
       "0    Potential therapeutic targets for combating SA...   \n",
       "1    Vaccines and Therapies in Development for SARS...   \n",
       "2    Integrated control of COVID-19 in resource-poo...   \n",
       "3    Emerging Therapeutic Modalities against COVID-19.   \n",
       "4    Recent trends in protein and peptide-based bio...   \n",
       "..                                                 ...   \n",
       "133  Treatment algorithm for COVID-19: a multidisci...   \n",
       "134  SARS-CoV-2: From Structure to Pathology, Host ...   \n",
       "135  Hydroxychloroquine in COVID-19: Potential Mech...   \n",
       "136  The pharmacological development of direct acti...   \n",
       "137  Pharmacological insight into potential therape...   \n",
       "\n",
       "                                                    GR  \n",
       "0                                                       \n",
       "1    R01AI13976802/National Institute of Allergy an...  \n",
       "2                                                       \n",
       "3    1R01CA24119401A1/NH/NIH HHS/United States;1R01...  \n",
       "4    R35 GM127042/GM/NIGMS NIH HHS/United States;R2...  \n",
       "..                                                 ...  \n",
       "133                                                     \n",
       "134  13SOL/Unitatea Executiva pentru Finantarea Inv...  \n",
       "135                                                     \n",
       "136                                                     \n",
       "137                                                     \n",
       "\n",
       "[138 rows x 7 columns]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "display(PM_terms_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "PM_terms_df.to_csv('output/PubMed_extract_ivermectin.csv',sep='\\t') "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "filtered_PM_df= PM_terms_df[PM_terms_df['PT'].str.contains('Trial')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "filtered_PM_df.to_csv('output/PubMed_extract_filtered_ivermectin.csv',sep='\\t')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
